Chemistry:Butaclamol

From HandWiki

Butaclamol (AY-23,028) is a type of antipsychotic which was never marketed.[1] Sold as the hydrochloride salt for use in research, the compound acts as a dopamine receptor antagonist.[2]

Synthesis:[3] Review:[4] Book chapter:[5]

Chemistry

pKa = 7.15 (uncorrected for ionic strength)[6]

See also

  • Dexclamol

References

  1. Dictionary of organic compounds - Google Books. CRC Press. 1985. ISBN 978-0-412-54090-5. https://books.google.com/books?id=wZawOvjGME0C&q=butaclamol&pg=PA1131. 
  2. "Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors". British Journal of Pharmacology 121 (4): 731–6. June 1997. doi:10.1038/sj.bjp.0701196. PMID 9208141. 
  3. "Neuroleptic agents of the benzocycloheptapyridoisoquinoline series. 1. Syntheses and stereochemical and structural requirements for activity of butaclamol and related compounds". Journal of Medicinal Chemistry 18 (2): 185–188. February 1975. doi:10.1021/jm00236a016. PMID 1168258. 
  4. "Butaclamol". Drugs of the Future 1 (4): 171. 1976. doi:10.1358/dof.1976.001.04.64761. 
  5. Chronicles of Drug Discovery, Volume 1, Edited by Jasjit S. Bindra and Daniel Lednicer, page 61, (L. G. Humber).
  6. "The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors". Journal of Medicinal Chemistry 28 (3): 399–400. March 1985. doi:10.1021/jm00381a022. PMID 2579238.